| Briana Nicole O'grady, DPT | |
|
10 High St, Wakefield, RI 02879-3176 | |
| (401) 783-8077 | |
| Not Available |
| Full Name | Briana Nicole O'grady |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 4 Years |
| Location | 10 High St, Wakefield, Rhode Island |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053929398 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | (* (Not Available)) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Orthopedics Rhode Island Inc | 7012225907 | 101 |
News Archive
Ziva Cooper, research director of the UCLA Cannabis Research Initiative, has been awarded a $3.9 million grant from the National Center for Complementary and Integrative Health at the NIH to study whether cannabis chemicals called terpenes can reduce the amount of opioid medication a person needs to reduce pain.
People age in different ways. Biological age is a metric that scientists use to predict health risks, the relevance of which can be enhanced by combining different markers. Particularly important markers are frailty and the epigenetic clock, write researchers from Karolinska Institutet in a study published in eLife.
In a letter addressed to Dr. Margaret Hamburg, the FDA commissioner, Ms. Norma Erickson, president of S.A.N.E. Vax, Inc. stated her research team has revealed the fact that in November 2001 the VRBPAC (Vaccines and Related Biological Products Advisory Committee) mistakenly allowed the vaccine manufacturer to use "CIN 2/3, AIS, or cervical cancer; i.e. CIN 2/3 or worse by histology- with virology to determine the associated HPV type- as the primary endpoint in the evaluation of a vaccine to prevent cervical cancer."
Accuray Incorporated, announced today that the Tulsa Cancer Institute is the first U.S. center to treat a patient with Accuray's TomoHDA System, the latest and most advanced innovation in the TomoTherapy product lineage designed to treat the full spectrum of cancer patients.
The growth of prenatal screening in Europe has reduced the number of babies being born per year with Down syndrome (DS) by an average of 54%, according to a new study published in the European Journal of Human Genetics by researchers from Massachusetts General Hospital and international Down syndrome organizations.
› Verified 6 days ago
| Provider Name | Orthopedics Rhode Island Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1407231293 PECOS PAC ID: 7012225907 Enrollment ID: O20150925001150 |
News Archive
Ziva Cooper, research director of the UCLA Cannabis Research Initiative, has been awarded a $3.9 million grant from the National Center for Complementary and Integrative Health at the NIH to study whether cannabis chemicals called terpenes can reduce the amount of opioid medication a person needs to reduce pain.
People age in different ways. Biological age is a metric that scientists use to predict health risks, the relevance of which can be enhanced by combining different markers. Particularly important markers are frailty and the epigenetic clock, write researchers from Karolinska Institutet in a study published in eLife.
In a letter addressed to Dr. Margaret Hamburg, the FDA commissioner, Ms. Norma Erickson, president of S.A.N.E. Vax, Inc. stated her research team has revealed the fact that in November 2001 the VRBPAC (Vaccines and Related Biological Products Advisory Committee) mistakenly allowed the vaccine manufacturer to use "CIN 2/3, AIS, or cervical cancer; i.e. CIN 2/3 or worse by histology- with virology to determine the associated HPV type- as the primary endpoint in the evaluation of a vaccine to prevent cervical cancer."
Accuray Incorporated, announced today that the Tulsa Cancer Institute is the first U.S. center to treat a patient with Accuray's TomoHDA System, the latest and most advanced innovation in the TomoTherapy product lineage designed to treat the full spectrum of cancer patients.
The growth of prenatal screening in Europe has reduced the number of babies being born per year with Down syndrome (DS) by an average of 54%, according to a new study published in the European Journal of Human Genetics by researchers from Massachusetts General Hospital and international Down syndrome organizations.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Briana Nicole O'grady, DPT 288 Blackberry Hill Dr, Wakefield, RI 02879-6554 Ph: (401) 919-4147 | Briana Nicole O'grady, DPT 10 High St, Wakefield, RI 02879-3176 Ph: (401) 783-8077 |
News Archive
Ziva Cooper, research director of the UCLA Cannabis Research Initiative, has been awarded a $3.9 million grant from the National Center for Complementary and Integrative Health at the NIH to study whether cannabis chemicals called terpenes can reduce the amount of opioid medication a person needs to reduce pain.
People age in different ways. Biological age is a metric that scientists use to predict health risks, the relevance of which can be enhanced by combining different markers. Particularly important markers are frailty and the epigenetic clock, write researchers from Karolinska Institutet in a study published in eLife.
In a letter addressed to Dr. Margaret Hamburg, the FDA commissioner, Ms. Norma Erickson, president of S.A.N.E. Vax, Inc. stated her research team has revealed the fact that in November 2001 the VRBPAC (Vaccines and Related Biological Products Advisory Committee) mistakenly allowed the vaccine manufacturer to use "CIN 2/3, AIS, or cervical cancer; i.e. CIN 2/3 or worse by histology- with virology to determine the associated HPV type- as the primary endpoint in the evaluation of a vaccine to prevent cervical cancer."
Accuray Incorporated, announced today that the Tulsa Cancer Institute is the first U.S. center to treat a patient with Accuray's TomoHDA System, the latest and most advanced innovation in the TomoTherapy product lineage designed to treat the full spectrum of cancer patients.
The growth of prenatal screening in Europe has reduced the number of babies being born per year with Down syndrome (DS) by an average of 54%, according to a new study published in the European Journal of Human Genetics by researchers from Massachusetts General Hospital and international Down syndrome organizations.
› Verified 6 days ago
Jennifer Leigh Kaye, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 730 Kingstown Rd, Wakefield, RI 02879 Phone: 401-284-3424 Fax: 401-284-3426 | |
Anne Kimpton, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 10 High St, Wakefield, RI 02879 Phone: 401-783-8077 Fax: 401-789-6029 | |
Meg O'neill, MS,PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 10 High St, Wakefield, RI 02879 Phone: 401-783-8077 Fax: 401-789-6029 | |
Dr. Adam Ramon Brissenden, PT, DPT, CERT. DN Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 163 Main St, Wakefield, RI 02879 Phone: 401-782-4049 Fax: 401-782-0890 | |
Dr. Dominique Marie Collins, PT, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 163 Main St, Wakefield, RI 02879 Phone: 401-782-4049 | |
Maureen H Redding, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1 High St, Wakefield, RI 02879 Phone: 401-783-8077 Fax: 401-789-6029 |